A Study to Evaluate ALN-AGT01 in Patients With Hypertension
Clinical trial NCT03934307 · COMPLETED
Trial details
- NCT number
- NCT03934307
- Sponsor
- Alnylam Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2022-04-20
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.